Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLASH trial of atuliflapon in uncontrolled asthma
jRCT2031210680Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2022
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Atuliflapon with Placebo (2 arms). Primary endpoint: Time to first CompEx Asthma event. Started Apr 2022; status: completed.
02
Drugs
atuliflapon
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2031210680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210680.